Keep an eye on Apple (AAPL). After finding support at $220, the tech giant is attempting to push higher. From its last traded price of $224.23, we’d like to see it initially retest $235. Helping, analysts at Evercore ISI just reiterated Apple’s outperform rating,...
With Bitcoin exploding higher, so is MicroStrategy (MSTR). As we said on October 8, “While you can always buy Bitcoin directly, you can also buy Bitcoin-related stocks, like MicroStrategy (MSTR). What makes it really exciting is its 252,220 Bitcoin holdings – which...
by Ian Cooper With Donald Trump taking office in January, investors may want to jump into stocks that exploded higher the last time he took office. That includes tech giants like Nvidia (NVDA). Between November 2016 and November 2020, NVDA ran from about $1.70,...
With Donald Trump winning the election, Bitcoin has been explosive. In fact, since the election, the digital currency ran from $69,384 to a recent high of $82,371 From here, analysts argue it could rally to $100,000. As noted by CNBC, James Butterfill, head of...
Keep an eye on Advanced Micro Devices (AMD). Oversold at $145, it’s just starting to pivot higher after finding strong support at $140. It’s also starting to pivot from overextensions on RSI, MACD and Williams’ %R. From $145, we’d like to see AMD initially refill its...
With Donald Trump back in the White House, cryptocurrencies are exploding. On Wednesday morning, Bitcoin hit an all-time high, tacking on more than $4,400 of value. And it could easily rally even more with Trump Administration support. Remember, Donald Trump and...
Keep an eye on oversold shares of Eli Lilly (LLY). The stock appears to have caught support after gapping from about $908 to $806.14. It’s also overextended on RSI, MACD and Williams’ %R. From its last traded price of $806.14, we’d like to see it initially refill its...
by Ian Cooper With markets dropping on earnings and uncertainty over the election, volatility is spiking. Late last week, the Volatility Index (VIX) jumped to a high of 21.44, where it’s now becoming over-extended. In fact, as we’ve seen two times before, when the VIX...
On October 31, we said Viking Therapeutics (VKTX) was a solid opportunity. Especially as the company was set to jump into Obesity Week where the company was presenting results from its Phase 2 VENTURE clinical trial with its subcutaneous formulation of VK2735....
In early October, we said, “Technically, Dell is oversold after dropping from $127 to $113.46, where it appears to have found strong support. From here, we’d like to see Dell retest $127 again initially.” At the time, the tech stock traded at around $117. Today, Dell...